Dr. David P. Wang, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Southwestern Medical School at Dallas (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 1,457
Licensed in Texas since 2018, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Texas Southwestern Medical School at Dallas
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
TX license R9315 (first issued 2018; active) -
Dermatopathology (Pathology) Physician
TX license R9315 (first issued 2018; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Westlake Dermatology PA (54 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,457
- Services billed
- 2,653
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 815 | 576 |
| Special stained specimen slides to examine tissue, initial procedure | 103 | 91 |
| Special stained specimen slides to identify organisms including interpretation and report | 41 | 36 |
| Pathology examination of tissue using a microscope, moderately low complexity | 36 | 30 |
| Special stained specimen slides to examine tissue, each additional procedure | 30 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 9 payments worth $208 in total to this clinician.
| Incyte Corporation | $102 |
|---|---|
| Sun Pharmaceutical Industries Inc. | $71.82 |
| Sandoz Inc. | $33.94 |
| Food and Beverage | $208 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.